Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    15824216 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Drug: Ranibizumab (Lucentis);   Drug: 0.5mg ranibizumab

Study has passed its completion date and status has not been verified in more than two years.